Dan Dubin

Vice Chairman, Head of BioPharma Investment Banking at SVB Leerink LLC

Dan Dubin

Dan Dubin

Vice Chairman, Head of BioPharma Investment Banking at SVB Leerink LLC

Overview
Career Highlights

Leerink Swann Strategic Advisors

RelSci Relationships

2242

Number of Boards

5

Relationships
RelSci Relationships are individuals Dan Dubin likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at SVB Leerink LLC

Relationship likelihood: Strong

Advisor at Pod Investment

Relationship likelihood: Strong

Former Chief Financial Officer & Partner at Wellington Management Company LP

Relationship likelihood: Strong

Founder at Studio Legale Broggini SA

Relationship likelihood: Strong

Managing General Partner at Oxford Bioscience Partners

Relationship likelihood: Strong

General Counsel at Leerink Transformation Partners LLC

Relationship likelihood: Strong

Operating Partner at Atlas Merchant Capital LLC

Relationship likelihood: Strong

Former President at Lazard Ltd.

Relationship likelihood: Strong

Managing Director, Chief Scientific Officer at SVB Leerink LLC

Relationship likelihood: Strong

Senior Managing Director, Mergers & Acquisitions at SVB Leerink LLC

Relationship likelihood: Strong

Paths to Dan Dubin
Potential Connections via
Relationship Science
You
Dan Dubin
Vice Chairman, Head of BioPharma Investment Banking at SVB Leerink LLC
Education
MD in Dermatology
Class of 1992

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

Graduate

Founded in 1769, Dartmouth is a member of the Ivy League and consistently ranks among the world's greatest academic institutions. Dartmouth has forged a singular identity for combining its deep commitment to outstanding undergraduate liberal arts and graduate education with distinguished research and scholarship in the Arts & Sciences and its three leading professional schools—the Geisel School of Medicine, Thayer School of Engineering, and the Tuck School of Business.

Career History
Vice Chairman, Head of BioPharma Investment Banking
Current

Founded by Jeffrey Leerink in 1995, Leerink Swann LLC, formerly Leerink Swann & Co., is a full-service healthcare-focused investment banking firm that offers institutional sales, equity research, institutional trading, corporate finance and asset management services. The firm's investment banking activities include private placements, public offerings, private investment in public equity (PIPEs), registered direct offerings (RDOs and mergers & acquisitions.Leerink Swann's investment perspectives are driven by proprietary insights from MEDACorp., a network of over 35,000 physicians, researchers and healthcare professionals in North America, Europe, Asia and around the world with expertise in: clinical medicine, basic sciences, biomedical research, regulatory affairs, intellectual property, public health and policy, managed care, pharmacy management/pharmacy benefits management, healthcare administration, healthcare facilities, healthcare information technology, allied health services and healthcare consulting.Leerink Swann offers equity healthcare research coverage of the following areas: biotechnology, life science tools and diagnostics, pharmaceuticals, medical supplies and devices and healthcare services. The firm is also a market maker in over 350 NASDAQ equities.

Founder
1996 - Current
Ambulatory Medical Director of Clinical Dermatology
1996 - 2002

Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated health care delivery network. BWH is the home of the Carl J. and Ruth Shapiro Cardiovascular Center, the most advanced center of its kind. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 900 physician-investigators and renowned biomedical scientists and faculty supported by more than $537 million in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative.

Boards & Committees
Chairman
Prior

MetaWorks, Inc., a subsidiary of United BioSource Corp., is a company headquartered in Medford, MA. The firm provides biopharmaceutical product, device, and health care development and commercialization consulting services. It was acquired by United BioSource Corp. on 17 Jan 06.

Transactions
Details Hidden

Assembly Biosciences, Inc. issued USD Common Stock

Details Hidden

Ardelyx, Inc. issued USD Common Stock

Details Hidden

Replimune Group, Inc. issued . USD Common Stock

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dan Dubin. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dan Dubin's profile does not indicate a business or promotional relationship of any kind between RelSci and Dan Dubin.